Teva Resigning From GPhA: Diversification, Size Led Firm's Priorities In Different Direction
This article was originally published in The Pink Sheet Daily
Executive Summary
Teva is leaving the Generic Pharmaceutical Association effective June 30; association may restructure to get Teva to change its mind.
You may also be interested in...
PhRMA Embraces Teva Across Brand-Generic Divide
PhRMA accepts Teva's request for membership; BIO rejected Teva five years ago.
GPhA Goes For Three: Billings To Head Tripartite Interim Leadership Team
Search for a permanent CEO has yet to begin in earnest while the association works on governance issues.
GPhA Goes For Three: Billings To Head Tripartite Interim Leadership Team
Search for a permanent CEO has yet to begin in earnest while the association works on governance issues.